Sun Pharmaceuticals | SUNP - Selling And Administration Expenses


Sun Pharmaceuticals reported INR24.89B in Selling and Administration Expenses for its fiscal quarter ending in March of 2025.





Selling And Administration Expenses Change Date
Aspen Pharmacare ZAR 4.35B 1.28B Dec/2025
Bharat Petroleum INR 8.66B 88.2M Dec/2025
Cipla INR 13.25B 101.8M Dec/2025
Dr.Reddys Laboratories INR 26.92B 482M Dec/2025
Jiangsu Hengrui CNY 3.01B 227.63M Dec/2025
Sh Fosun Pharma CNY 4.44B 1.32B Dec/2025
Sun Pharmaceuticals INR 24.89B 637.6M Mar/2025
UPL INR 15.8B 660M Sep/2025